0 оценок0% нашли этот документ полезным (0 голосов)
48 просмотров12 страниц
U.S. patent 7842714: Ketorolac tromethamine compositions for treating ocular pain. Granted to Farnes et. al. (6 total) on 2010-11-30 (filed 2009-03-02) and assigned to Allergan, Inc.. Currently involved in at least 1 patent litigation: Allergan Inc. v. Akorn Inc. et. al. (Delaware). See http://news.priorsmart.com for more info.
Оригинальное название
Ketorolac tromethamine compositions for treating ocular pain (US patent 7842714)
U.S. patent 7842714: Ketorolac tromethamine compositions for treating ocular pain. Granted to Farnes et. al. (6 total) on 2010-11-30 (filed 2009-03-02) and assigned to Allergan, Inc.. Currently involved in at least 1 patent litigation: Allergan Inc. v. Akorn Inc. et. al. (Delaware). See http://news.priorsmart.com for more info.
Авторское право:
Public Domain
Доступные форматы
Скачайте в формате PDF, TXT или читайте онлайн в Scribd
U.S. patent 7842714: Ketorolac tromethamine compositions for treating ocular pain. Granted to Farnes et. al. (6 total) on 2010-11-30 (filed 2009-03-02) and assigned to Allergan, Inc.. Currently involved in at least 1 patent litigation: Allergan Inc. v. Akorn Inc. et. al. (Delaware). See http://news.priorsmart.com for more info.
Авторское право:
Public Domain
Доступные форматы
Скачайте в формате PDF, TXT или читайте онлайн в Scribd